Literature DB >> 7040216

Sex hormones enhance immunoglobulin synthesis by human peripheral blood lymphocytes.

A P Weetman, A M McGregor, B R Smith, R Hall.   

Abstract

Using a protein A haemolytic plaque assay to detect immunoglobulin synthesis by human peripheral blood lymphocytes cultured with pokeweed mitogen, we have shown a significant increase in IgG plaque-forming cells in the presence of physiological concentrations of testosterone and oestradiol. Higher concentrations of these steroids inhibit plaque-forming cells. There was no difference in the response to testosterone and oestradiol of lymphocytes derived from male subjects or menstruating or post-menopausal females.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7040216     DOI: 10.1016/0165-2478(81)90064-x

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  5 in total

Review 1.  Anabolic-androgenic steroids: In cell culture.

Authors:  C D Kochakian; A A Welder
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-06       Impact factor: 2.416

2.  In vitro functions of lymphocytes during high-dose medroxyprogesterone acetate (MPA) treatment.

Authors:  M Grönroos; J Eskola
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

3.  IgG-induced experimental immune synovitis: hormonal modulation of in vitro splenic immune responses to homologous antigens.

Authors:  T F Kresina; I A Rosner; V M Goldberg; B A Boja; R W Moskowitz
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

4.  Effects of 17 beta-oestradiol on function of lymphocytes from normal donors and patients with common variable immunodeficiency (CVID).

Authors:  M Evagelatou; A D Webster; J Farrant
Journal:  Clin Exp Immunol       Date:  1994-11       Impact factor: 4.330

5.  Sex-Steroid Signaling in Lung Diseases and Inflammation.

Authors:  Nilesh Sudhakar Ambhore; Rama Satyanarayana Raju Kalidhindi; Venkatachalem Sathish
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.